Supernus Pharmaceuticals, Inc. financial data

Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
Location
9715 Key West Avenue, Rockville, MD
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 173 % +53.4%
Quick Ratio 25.3 % +70.4%
Debt-to-equity 39.3 % -51.7%
Return On Equity 2.82 % -37.4%
Return On Assets 1.69 % -25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 55.1M shares +0.94%
Common Stock, Shares, Outstanding 55M shares +1.46%
Entity Public Float 1.55B USD -5.44%
Common Stock, Value, Issued 55K USD 0%
Weighted Average Number of Shares Outstanding, Basic 55M shares +0.87%
Weighted Average Number of Shares Outstanding, Diluted 55.7M shares +2.24%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 168M USD +24.2%
Research and Development Expense 26.2M USD +7.4%
Costs and Expenses 146M USD -4.83%
Operating Income (Loss) 22.6M USD
Nonoperating Income (Expense) 3.73M USD +712%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 26.3M USD
Income Tax Expense (Benefit) 6.39M USD
Net Income (Loss) Attributable to Parent 19.9M USD
Earnings Per Share, Basic 0.36 USD/shares
Earnings Per Share, Diluted 0.36 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 52.1M USD +111%
Marketable Securities, Current 368M USD +170%
Accounts Receivable, after Allowance for Credit Loss, Current 152M USD +11.7%
Inventory, Net 68.2M USD -24.7%
Assets, Current 591M USD +39.5%
Property, Plant and Equipment, Net 12.3M USD -13.5%
Operating Lease, Right-of-Use Asset 27.8M USD -4.73%
Intangible Assets, Net (Excluding Goodwill) 560M USD -15.5%
Goodwill 117M USD 0%
Other Assets, Noncurrent 35.9M USD -6.75%
Assets 1.32B USD +1.76%
Accounts Payable, Current 4.63M USD +5.18%
Employee-related Liabilities, Current 17M USD +8.65%
Accrued Liabilities, Current 82.6M USD -0.52%
Liabilities, Current 309M USD +22.2%
Deferred Income Tax Liabilities, Net 11.4M USD -74.2%
Operating Lease, Liability, Noncurrent 30.3M USD -11.4%
Other Liabilities, Noncurrent 7.29M USD -16.6%
Liabilities 358M USD -3.97%
Accumulated Other Comprehensive Income (Loss), Net of Tax -372K USD +79%
Retained Earnings (Accumulated Deficit) 503M USD +1.05%
Stockholders' Equity Attributable to Parent 957M USD +4.08%
Liabilities and Equity 1.32B USD +1.76%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 38.4M USD -21.8%
Net Cash Provided by (Used in) Financing Activities 1.57M USD -98%
Net Cash Provided by (Used in) Investing Activities -51.6M USD -122%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 55M shares +0.83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.7M USD -103%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 52.1M USD +111%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 59.6M USD -15.5%
Deferred Tax Assets, Gross 194M USD -9.47%
Operating Lease, Liability 40M USD -5.26%
Payments to Acquire Property, Plant, and Equipment 248K USD -10.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 20.1M USD
Lessee, Operating Lease, Liability, to be Paid 50.8M USD -11.4%
Property, Plant and Equipment, Gross 28.9M USD +1.45%
Operating Lease, Liability, Current 9.68M USD +20.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.65M USD -1.14%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.26M USD +5.28%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -5.48M USD -1160%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.97M USD -16%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.67M USD -18.6%
Deferred Tax Assets, Operating Loss Carryforwards 113M USD -10.9%
Unrecognized Tax Benefits 4.32M USD -29.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.53M USD -15.1%
Operating Lease, Payments 4M USD +15.8%
Additional Paid in Capital 455M USD +7.28%
Amortization of Intangible Assets 20.1M USD 0%
Depreciation, Depletion and Amortization 20.7M USD +0.72%
Deferred Tax Assets, Net of Valuation Allowance 135M USD -6.52%
Share-based Payment Arrangement, Expense 6.55M USD +7.62%
Interest Expense 0 USD -100%